TCTN2 Antikörper (C-Term) (PE-Cy7)
Kurzübersicht für TCTN2 Antikörper (C-Term) (PE-Cy7) (ABIN1713233)
Target
Alle TCTN2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human TCTN2
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM(1:100-500)
Optimal working dilution should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- TCTN2 (Tectonic Family Member 2 (TCTN2))
-
Andere Bezeichnung
- TCTN2
-
Hintergrund
-
Synonyms: C12orf38, FLJ12975, MKS8, OTTHUMP00000239215, OTTHUMP00000239216, Tctn2, TECT2, TECT2_HUMAN, Tectonic family member 2, Tectonic-2.
Background: Defects in TCTN2 are the cause of Meckel syndrome type 8 (MKS8) [MIM:613885]. A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly.
-
Pathways
- Proton Transport
Target
-